Capricor Therapeutics Investors Face Securities Lawsuit Deadline

AI-generated NewsSnap summary based on source reporting.
Published: 2026-08-30T07:11:12Z
Category: business
Source: AP News (via NewMediaWire)
Original source

Kessler Topaz Meltzer & Check, LLP is urging Capricor Therapeutics (CAPR) investors to contact the firm regarding a pending securities class action lawsuit. Investors who acquired securities between December 17, 2025, and July 26, 2026, face a lead plaintiff deadline of September 28, 2026. This action is significant for shareholders seeking to participate in the legal proceedings.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai